ArticleFrontiers in immunology2024

PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy.

Lingbin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.